Uncategorised - European Medical Journal

JAK Inhibitors in Dermatological Autoimmunity for People with Down Syndrome

Individuals with Down syndrome exhibit a hyperactive immune system marked by increased interferon signalling and cytokine production.

The word spotlight on a blue background

Spotlight: January 2025

Catch up on January’s top pharma news, from major industry deals and cutting-edge medical innovations to advancements in women’s health.

Erratum: Depressive Symptoms and Left Ventricular Diastolic Dysfunction Among Men and Women with HIV

Combining Oral and UV Therapy for Vitiligo

A recent clinical trial has shown promising results in treating severe, active vitiligo through a combination of oral medication and phototherapy, offering new hope for managing this challenging condition.

ESMO Asia 2024: Urothelial Cancer Symposium

In this symposium chaired by Ravindran Kanesvaran, renowned experts Enrique Grande, Syed Hussain, and Ben Tran discuss the evolving…

Improving Management of Food Allergy

The symposium was held on the final day of the European Academy of Allergy and Clinical Immunology’s (EAACI) Food Allergy and Anaphylaxis…

IPF Gene Variant May Protect Lungs Post-COVID-19

A recent study has uncovered a new connection between genetic risk factors for idiopathic pulmonary fibrosis and the development of post-COVID-19 lung abnormalities.

Improving Quality of Life in BPH Treatment Advances

Recent advancements in ejaculation-preserving techniques during HoLEP have yielded encouraging results.

Fetuses with Congenital Heart Disease Have Impaired Placental Function and Growth

Reduced placental flow and malperfusion defects in fetuses with CHD highlight potential pathways impacting growth and outcomes.

Charl van Zyl, Lundbeck Pharmaceuticals

Lundbeck’s Charl van Zyl on a new era in neurology

The team are joined by Charl van Zyl, President and CEO, Lundbeck Pharmaceuticals, to discuss advances in the treatment of neurological disorders.